Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation

Clinical Transplantation

Volumn 22, Issue 4, 2008, Pages 462-468

  Dolgos, Szilveszter ^a   Hartmann, Anders ^a,e   Bønsnes, Stine ^a   Ueland, Thor ^b   Isaksen, Gunhild Aker ^c   Godang, Kristin ^c   Pfeffer, Per ^d   Bollerslev, Jens ^c  

^a Section of Nephrology   (Norway)

^b Research Institute for Internal Medicine   (Norway)

^c Section of Endocrinology   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bone mineral density; Fracture rate; Kidney failure; Osteopenia; Osteoporosis; Transplantation

Indexed keywords

ANTIVITAMIN K; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; ESTROGEN; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; PARATHYROID HORMONE; STEROID; THIAZIDE DIURETIC AGENT; WARFARIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; FRACTURE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PERITONEAL DIALYSIS; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; UREMIA;

ABSORPTIOMETRY, PHOTON; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 48249121953     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00810.x     Document Type: Article

References (20)

1. Lunt M, Felsenberg D, Adams J et al. Population-based geographic variations in DXA bone density in Europe: The European Vertebral Osteoporosis Study (EVOS). Osteoporos Int 1997: 7: 175.
2. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991: 325: 544.
3. Hruska KA, TeitelbaumSL. Renal osteodystrophy. N Engl J Med 1995: 333: 166.
4. Monier-Faugere M-C, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000: 11: 1093.
5. Kodras K, Haas M. Effect of kidney transplantation on bone. Eur J Clin Invest 2006: 36: 63.
6. WHO. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis: Report of World Health Organization Study Group. Geneva: World Health Organization, 1994.
7. Gjesdal CG, Aanderud SJ, Haga HJ, Brun JG, Tell GS. Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: Suitability of the reference values. Osteoporos Int 2004: 15: 525.
8. Ugur A, Guvener N, Isklar I, Turan M, Erdal R, Haberal M. Osteoporosis after renal transplantation: Single center experience. Transplantation 2001: 71: 645.
9. Mora S, Gilsanz V. Establishment of peak bone mass. Endocrinol Metab Clin North Am 2003: 32: 39.
10. Fredericson M, Kent K. Normalization of bone density in a previously amenorrheic runner with osteoporosis. Med Sci Sports Exerc 2005: 37: 1481.
11. Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health 2006: 15: 1028.
12. Chesnut CH. Bone mass and exercise. Am J Med 1993: 95: 34.
13. Xie LQ, Liu CL. Development of theory of skeletal adaptation to mechanical loading. Space Med Med Eng (Beijing) 1999: 12: 226.
14. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998: 102: 274.
15. Martin KJ, Olgaard K, Coburn JW et al. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004: 43: 558.
16. David DS, Sakai S, Brennan BL et al. Hypercalcemia after renal transplantation: Long-term follow-up data. N Engl J Med 1973: 289: 398.
17. Taal MW, Masud T, Green D, CassidyMJ. Risk factors for reduced bone density in hemodialysis patients. Nephrol Dial Transplant 1999: 14: 1922.
18. Edelstein SL, Barrett-Connor E. Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol 1993: 138: 160.
19. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 1999: 33: 287.
20. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000: 36: 1115.